Published in

American Association for Cancer Research, Clinical Cancer Research, 12(29), p. 2176-2178, 2023

DOI: 10.1158/1078-0432.ccr-23-0420

Links

Tools

Export citation

Search in Google Scholar

ctDNA Monitoring for Small Cell Lung Cancer: Ready for Prime Time?

Journal article published in 2023 by Bruna Pellini ORCID, Aadel A. Chaudhuri ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

SummarySmall cell lung cancer (SCLC) is the deadliest form of lung cancer and has few precision medicine approaches available. A recent study analyzed circulating tumor DNA (ctDNA) in 33 patients with extensive-stage SCLC and showed that ctDNA levels and response patterns correlate strongly with clinical response and survival outcomes.See related article by Sivapalan et al., p. 2310